Itron (NASDAQ:ITRI) Stock Price Target Raised at JPMorgan Chase & Co.

Itron (NASDAQ:ITRI) had its target price increased by JPMorgan Chase & Co. from $107.00 to $109.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has an “overweight” rating on the scientific and technical instruments company’s stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 17.37% from the stock’s current price.

A number of other research analysts have also recently commented on ITRI. Zacks Research cut shares of Itron from a “strong-buy” rating to a “hold” rating in a report on Monday, October 19th. Oppenheimer reaffirmed an “outperform” rating on shares of Itron in a report on Wednesday. Seaport Research Partners reiterated a “buy” rating and set a $150.00 price objective on shares of Itron in a research report on Wednesday, July 29th. Robert W. Baird set a $125.00 price objective on shares of Itron in a research note on Wednesday, July 29th. Finally, Weiss Ratings upgraded shares of Itron from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, October 12th. Nine analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $129.20.

Itron Price Performance

Shares of Itron stock traded down $1.68 during trading on Wednesday, reaching $92.87. 475,364 shares of the company’s stock were exchanged, compared to its average volume of 820,586. The company has a debt-to-equity ratio of 0.96, a quick ratio of 2.29 and a current ratio of 2.75. Itron has a 1-year low of $77.77 and a 1-year high of $142.00. The company has a market cap of $4.07 billion, a P/E ratio of 15.47, a PEG ratio of 1.05 and a beta of 1.32. The firm’s 50-day moving average price is $91.26 and its 200 day moving average price is $91.10.

Itron (NASDAQ:ITRI) last released its quarterly earnings data on Tuesday, October 27th. The scientific and technical instruments company reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.56 by $0.38. Itron had a return on equity of 19.26% and a net margin of 11.90%. The business had revenue of $599.33 million for the quarter, compared to analyst estimates of $595.50 million. During the same period last year, the firm posted $1.54 earnings per share. Itron’s revenue was up 3.0% compared to the same quarter last year. As a group, research analysts anticipate that Itron will post 6.41 earnings per share for the current year.

Insider Transactions at Itron

In other news, SVP Justin K. Patrick sold 10,210 shares of the business’s stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $97.36, for a total transaction of $994,045.60. Following the sale, the senior vice president directly owned 22,065 shares in the company, valued at approximately $2,148,248.40. The trade was a 31.63% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Joan S. Hooper sold 4,406 shares of the company’s stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $98.86, for a total value of $435,577.16. Following the completion of the transaction, the chief financial officer directly owned 117,113 shares of the company’s stock, valued at $11,577,791.18. This represents a 3.63% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 17,903 shares of company stock valued at $1,753,521 over the last three months. Company insiders own 1.77% of the company’s stock.

Institutional Investors Weigh In On Itron

Several hedge funds have recently added to or reduced their stakes in the business. Oppenheimer & Co. Inc. grew its holdings in Itron by 2.2% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 13,997 shares of the scientific and technical instruments company’s stock worth $1,209,000 after acquiring an additional 300 shares during the last quarter. Pinnacle Associates Ltd. increased its position in Itron by 5.2% in the 3rd quarter. Pinnacle Associates Ltd. now owns 289,185 shares of the scientific and technical instruments company’s stock valued at $24,968,000 after acquiring an additional 14,344 shares during the period. New Wave Wealth Advisors LLC bought a new position in shares of Itron during the third quarter valued at $702,000. IFP Advisors Inc raised its stake in shares of Itron by 38.7% during the third quarter. IFP Advisors Inc now owns 803 shares of the scientific and technical instruments company’s stock valued at $69,000 after acquiring an additional 224 shares during the last quarter. Finally, Robertson Stephens Wealth Management LLC bought a new position in shares of Itron during the third quarter valued at $321,000. 96.19% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting Itron

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Q3 earnings beat expectations: Itron reported adjusted EPS of $1.94, well above the $1.56 analyst consensus, while revenue rose 3% year over year to $599.3 million, slightly exceeding estimates. Net income increased to $71.4 million, supported by stronger operating margins. Itron Stock Jumps as Q3 Earnings Showcase Margin Strength
• Positive Sentiment: Recurring revenue and backlog improved: Annual recurring revenue increased 25% to $423 million, while total backlog reached $4.3 billion. Operating cash flow was $102 million and free cash flow was $96 million, providing additional support for the bullish earnings reaction. Itron Q3 Revenue Rises 3% to $599 Million
• Positive Sentiment: Full-year outlook was maintained or raised: Itron projected fourth-quarter revenue of $621 million to $636 million and full-year 2026 revenue of $2.37 billion to $2.385 billion. Needham raised its price target from $128 to $137 and upgraded its view to “buy,” implying substantial upside from current levels. Needham Itron Price Target
• Neutral Sentiment: Analyst views remain mixed: BNP Paribas Exane cut its target from $115 to $105 but retained an “outperform” rating. The lower target may limit enthusiasm, although it still indicates potential appreciation. BNP Paribas Exane Lowers Itron Price Target
• Negative Sentiment: Insider selling is a cautionary signal: Company insiders reportedly made no purchases and 42 sales during the past six months. While these transactions may reflect portfolio or compensation decisions, the absence of insider buying could weigh on sentiment.

Itron Company Profile

Itron, Inc is a technology company that provides solutions to utilities and cities for managing electricity, natural gas, and water resources. Its offerings help organizations measure consumption, collect and analyze data, improve operational efficiency, and support more reliable and sustainable delivery of essential services.

The company’s portfolio includes smart meters, advanced metering infrastructure, communications networks, sensors, data management systems, and utility software.